These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10516376)

  • 1. Review of issues relating to iron and infection.
    Fishbane S
    Am J Kidney Dis; 1999 Oct; 34(4 Suppl 2):S47-52. PubMed ID: 10516376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does iron cause bacterial infections in patients with end stage renal disease?
    Cieri E
    ANNA J; 1999 Dec; 26(6):591-6. PubMed ID: 10876474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aggressively driven intravenous iron therapy on infectious complications in end-stage renal disease patients on maintenance hemodialysis.
    Bansal A; Sandhu G; Gupta I; Kalahalli S; Nayak R; Zouain E; Chitale RA; Meisels I; Chan G
    Am J Ther; 2014; 21(4):250-3. PubMed ID: 22832501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron and cardiac disease in the end-stage renal disease setting.
    Besarab A
    Am J Kidney Dis; 1999 Oct; 34(4 Suppl 2):S18-24. PubMed ID: 10516371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Issues related to iron replacement in dialyzed patients].
    Kessler M
    Nephrol Ther; 2006 Sep; 2 Suppl 4():S266-73. PubMed ID: 17373269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
    Riedel MK; Morgenstern T
    Dtsch Med Wochenschr; 2004 Sep; 129(36):1849-53. PubMed ID: 15368155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble transferrin receptor is correlated with erythropoietin sensitivity in dialysis patients.
    Daschner M; Mehls O; Schaefer F
    Clin Nephrol; 1999 Oct; 52(4):246-52. PubMed ID: 10543327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathobiology of the role of iron in infection.
    Sunder-Plassmann G; Patruta SI; Hörl WH
    Am J Kidney Dis; 1999 Oct; 34(4 Suppl 2):S25-9. PubMed ID: 10516372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upper limit of serum ferritin: misinterpretation of the 2006 KDOQI anemia guidelines.
    Fishbane S
    Semin Dial; 2008; 21(3):217-20. PubMed ID: 18248518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients.
    Drüeke TB; Bárány P; Cazzola M; Eschbach JW; Grützmacher P; Kaltwasser JP; Macdougall IC; Pippard MJ; Shaldon S; van Wyck D
    Clin Nephrol; 1997 Jul; 48(1):1-8. PubMed ID: 9247771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of ferritin for optimizing anemia therapy in chronic kidney disease.
    Nakanishi T; Kuragano T; Nanami M; Otaki Y; Nonoguchi H; Hasuike Y
    Am J Nephrol; 2010; 32(5):439-46. PubMed ID: 20881381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National perspective on iron therapy as a clinical performance measure for maintenance hemodialysis patients.
    Owen WF; Szczech L; Johnson C; Frankenfield D
    Am J Kidney Dis; 1999 Oct; 34(4 Suppl 2):S5-S11. PubMed ID: 10516369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients.
    Mircescu G; Gârneata L; Capusa C; Ursea N
    Nephrol Dial Transplant; 2006 Jan; 21(1):120-4. PubMed ID: 16144853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of ferritin as a marker of anemia in end stage renal disease.
    Dennison HA
    ANNA J; 1999 Aug; 26(4):409-14; quiz 419-20. PubMed ID: 10838972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Issues related to iron replacement in chronic kidney disease.
    Agarwal R; Warnock D
    Semin Nephrol; 2002 Nov; 22(6):479-87. PubMed ID: 12430092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron and infection: clinical experience.
    Hoen B
    Am J Kidney Dis; 1999 Oct; 34(4 Suppl 2):S30-4. PubMed ID: 10516373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anemia of chronic renal failure: new treatment alternative.
    Seiler S
    CANNT J; 2000; 10(3):35-9, 43-8; quiz 40-2, 49-51. PubMed ID: 11799582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current recommendations on iron therapy in anaemia of chronic renal failure.
    Singh NP; Anuradha S; Agarwal SK
    J Assoc Physicians India; 2002 Oct; 50():1295-302. PubMed ID: 12568217
    [No Abstract]   [Full Text] [Related]  

  • 19. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron status as measured by serum ferritin: the marker and its limitations.
    Cavill I
    Am J Kidney Dis; 1999 Oct; 34(4 Suppl 2):S12-7. PubMed ID: 10516370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.